En español
NIDA

NIDA announces 2012 SCOR Awards for research on gender differences

Announcement

November 01, 2012

NIDA has awarded grants to Yale University, the Medical University of South Carolina, and the University of Minnesota to explore sex differences in drug addiction.

NIDA has awarded grants to Yale University, the Medical University of South Carolina, and the University of Minnesota to explore sex differences in drug addiction. These three grants are part of the Specialized Centers of Research (SCOR) on Sex Differences program developed and coordinated by NIH’s Office of Research on Women’s Health, which has recently awarded a total of 11 SCORs among NIH Institutes. Each NIDA grant has translational implications for drug abuse medications that take gender into account.  Recipients will receive approximately $1,000,000 per year for 5 years to support their research.

The Yale program, led by Dr. Sherry McKee, aims to develop effective smoking cessation treatments for women, who have lower smoking quit rates and greater smoking-related health consequences than men (read Yale’s press release at http://news.yale.edu/2012/07/03/new-nih-funded-yale-center-treat-women-smokers).

The Medical University of South Carolina program, led by Dr. Kathleen Brady, will examine relationships among gender, stress, and craving in cocaine and nicotine use in order to develop potential medications to prevent stress-based cocaine relapse and promote smoking cessation.

The University of Minnesota program, led by Dr. Marilyn Carroll, will focus on the interactions of sex differences, hormonal status (e.g., progesterone levels), and impulsivity with cigarette smoking and cocaine use to improve existing medication treatments for those addictions.

The RFA can be viewed at http://grants1.nih.gov/grants/guide/rfa-files/RFA-OD-11-003.html.

For more information, contact the NIDA press office at media@nida.nih.gov or 301-443-6245. 

Contact:
NIDA Press Office
301-443-6245
media@nida.nih.gov

About the National Institute on Drug Abuse (NIDA): The National Institute on Drug Abuse (NIDA) is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. Fact sheets on the health effects of drugs and information on NIDA research and other activities can be found at www.drugabuse.gov, which is now compatible with your smartphone, iPad or tablet. To order publications in English or Spanish, call NIDA’s DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or email requests to drugpubs@nida.nih.gov. Online ordering is available at drugpubs.drugabuse.gov. NIDA’s media guide can be found at www.drugabuse.gov/publications/media-guide/dear-journalist, and its easy-to-read website can be found at www.easyread.drugabuse.gov. You can follow NIDA on Twitter and Facebook.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH. . .Turning Discovery Into Health®

News Releases

2017

2016

2015

2014

2013

2012

2011

2010

Get this Publication

    Cite this article

    NIDA. (2012, November 1). NIDA announces 2012 SCOR Awards for research on gender differences. Retrieved from https://www.drugabuse.gov/news-events/news-releases/2012/11/nida-announces-2012-scor-awards-research-gender-differences

    press ctrl+c to copy
    Receive Latest Science Articles in your Email!
    You will only receive messages related to Latest Science